TDOC TELADOC HEALTH INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 26 analyst firms say about TELADOC HEALTH INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
25 rated views · 26 analyst/firm records · 26 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 12 reports on TDOC from 11 analyst firms in the last 90 days (26 firms in the past year).
Comparing each firm's latest target with its previous one: 6 raised their price target and 1 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wells Fargo raised its target from $6.00 (set 26 Aug 2026) to $8.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | Hold | 20 May 2026 | — |
| Bank of America Securities | Allen Lutz | Buy | 7 Jul 2026 | 10.50 USD |
| Barclays | Glen Santangelo | Hold | 26 Mar 2026 | 7.00 USD |
| BMO Capital Markets | Sean W Dodge | Hold | 29 Oct 2026 | 7.00 USD |
| BTIG | David M Larsen | Hold | 22 Jul 2026 | — |
| Canaccord Genuity | Richard Close | Buy | 30 Jul 2026 | 10.00 USD |
| Cantor Fitzgerald | Sarah James | Buy | 26 Feb 2026 | 10.00 USD |
| Citigroup | Daniel Grosslight | Hold | 3 Aug 2026 | 7.50 USD |
| Deutsche Bank | George Hill | Buy | 10 Mar 2026 | 11.00 USD |
| Evercore ISI | Elizabeth Anderson | Hold | 7 Jul 2026 | 6.00 USD |
| Goldman Sachs | David H Roman | Buy | 26 Feb 2026 | 8.00 USD |
| Jefferies | Brian G Tanquilut | Hold | 19 Oct 2026 | Conflicting reports · excluded |
| JPMorgan | Lisa Gill | Hold | 30 Oct 2026 | 10.00 USD |
| KeyBanc Capital Markets | Scott Schoenhaus | Hold | 24 Sep 2026 | — |
| Leerink Partners | Michael Cherny | Hold | 29 Jul 2026 | 7.50 USD |
| Mizuho | Steven Valiquette | Hold | 21 Jul 2026 | 6.00 USD |
| Needham | Ryan MacDonald | Hold | 29 Oct 2026 | — |
| Oppenheimer | Michael Wiederhorn | Buy | 3 Mar 2026 | 7.00 USD |
| Piper Sandler | Jessica Tassan | Buy | 26 Feb 2026 | 9.00 USD |
| Stifel | David Grossman | Hold | 29 Oct 2026 | 6.50 USD |
| TD Cowen | Charles Rhyee | Hold | 26 Feb 2026 | 6.00 USD |
| Truist | Jailendra Singh | Hold | 1 Jun 2026 | 8.00 USD |
| UBS | Kevin Caliendo | Hold | 2 Aug 2026 | 6.50 USD |
| Weiss Ratings | Unnamed analyst | — | 19 Aug 2026 | — |
| Wells Fargo | Stan Berenshteyn | Hold | 26 Aug 2026 | 6.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:03 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.